Μακροπρόθεσμη αποτελεσματικότητα και ασφάλεια του sotatercept για τη θεραπεία της πνευμονικής αρτηριακής υπέρτασης (ΠΑΥ)

Μακροπρόθεσμη αποτελεσματικότητα και ασφάλεια του sotatercept για τη θεραπεία της πνευμονικής αρτηριακής υπέρτασης (ΠΑΥ)

PULSAR open-label extension: Long-term efficacy and safety of sotatercept for the treatment of pulmonary arterial hypertension (PAH) Pulmonary arterial hypertension (PAH) is a progressive disease driven by pulmonary vascular remodeling. Sotatercept acts as a...

7 Diseases That May Cause Pulmonary Hypertension

BY WENDY HENDERSON Pulmonary hypertension (PH) is a chronic lung disease where the blood pressure in the lungs is dangerously elevated. This leads to the right side of the heart having to work much harder to pump oxygenated blood back into the lungs and can lead to...

Debunking 5 Major Lung Transplant Myths

Professor Daniel Chambers from the Queensland Lung Transplant Service, at The Prince Charles Hospital in Brisbane, Australia, debunks 10 myths about lung transplants for pulmonary hypertension patients and other patients with lung problems. Read about five of the...
Translate »

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!